Sourcing strategy
THREE CONTINENTS.
ONE STANDARD.
Voleni sources premium medical cannabis flower from trusted partners in Canada, South Africa and Thailand, ensuring quality, consistency and long term supply security.
Quality control
QC travels to the source.
Our QC team travels globally to every partner facility and tests each batch before release. Multi-level quality control, so nothing is approved until it clears every check.
Canada.
World leading pharmaceutical grade cultivation.
Federally legal medical cannabis since 2001 and the global benchmark for pharmaceutical grade indoor growing. Our Health Canada licensed partners deliver consistent, premium flower.
- ◇Indoor and hybrid greenhouse cultivation
- ◇Decades of cultivation research and genetic refinement
- ◇GMP certified facilities with proven EU export experience
- ◇Consistent cannabinoid and terpene profiles batch to batch
- ◇Established cold chain logistics into the UK and EU
Pharma grade
GMP & GPP certified production
Genetics
Award winning, stable cultivars
Reliability
Mature export infrastructure
South Africa.
Premium quality at remarkable value.
World class indoor and greenhouse cultivation, over 300 days of sunshine and low energy costs. SAHPRA licensed, GACP and GMP compliant partners supply premium flower at remarkable value.
- ◇Both indoor cleanrooms and modern greenhouse facilities
- ◇Significantly lower production cost per gram
- ◇Scalable capacity for growing UK patient demand
- ◇SAHPRA licensed, GACP & GMP compliant operations
- ◇Direct export corridor to UK importers
Value
Best quality to price ratio
Scale
Hectares of licensed capacity
Sustainable
Lower energy & carbon footprint
Thailand.
Our newest supply region, built for growth.
Our newest supply region. Year round growing conditions, a maturing licensed export program and modern indoor grow rooms add capacity and resilience to our global supply chain.
- ◇Purpose built indoor grow rooms with full climate control
- ◇Multiple harvests per season for scalable supply
- ◇Significantly lower production cost per gram
- ◇Licensed export program serving international markets
- ◇Strengthens supply security alongside Canada and South Africa
Expansion
Our newest sourcing region
Climate
Year round growing season
Resilient
Third supply corridor
Future ready
VOLENI OWN GENETICS
Voleni is building a vertically integrated future. From proprietary cultivars to our own cultivation, we are securing supply for the next decade.
Proprietary clones
Mother stock to harvest, fully owned.
2027
Facilities operational.
Our own strain genetics will be grown in facilities ready for our import. Licensed cultivation infrastructure commissioned and producing first commercial batches under GACP.
2028
Voleni strains ready.
Voleni own strains that will be ready by 2028. Proprietary cultivars developed for the UK market, delivering consistent cannabinoid profiles and full traceability from plant to patient.
Plant to patient journey
- 01
Austria TC lab
Tissue culture mother stock, phytosanitary certified
- 02
Transfer
Sealed cold chain to licensed cultivation site
- 03
Facility
GACP cultivation, propagation to flower
- 04
Harvest & cure
GMP processing, lab tested batches
- 05
Export to UK
Licensed import, distributed to pharmacies
Genetic security
Tissue culture propagation.
Our proprietary strains are held in tissue culture at partner laboratories in Germany and Austria. This guarantees maximum security from pests, pathogens and genetic loss while maintaining absolute consistency across every batch.
All strains are fully licensed and legally registered with full phytosanitary documentation. They are ready to distribute through regulated channels across Europe.
Pest free
Complete protection from insects, mites and cross contamination in sealed sterile conditions.
Genetic fidelity
Exact clones with zero genetic drift, preserving the original cultivar profile indefinitely.
Disease free
Elimination of pathogens and viruses that can spread through conventional mother stock.
Rapid scale
Commercial volumes multiplied from a single explant to meet growing patient demand.
Our supply chain
Plant to patient.
Every gram passes through six audited stages, from licensed cultivation overseas to UK pharmacy dispensing.
01
Cultivation
GACP / GPP
02
Lab Testing
Independent
03
Packaging
Medical grade
04
Export
Cold chain
05
UK Import
MHRA licensed
06
Pharmacy
To patient
Supplier requirements
Non-negotiables.
GACP Standards
Good Agricultural and Collection Practice across every facility.
Quality Testing
Independent verification of potency, contaminants and microbiology.
Full Traceability
From plant to patient, every batch documented and accountable.
Secure Chain
Audited logistics, custody and storage at every stage.